Author details

Full Name

Kara Johnson

Affiliation

Knight Cancer Institute, Oregon Health & Science University

ORCID

Career Start Year

1991

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37199721	Patient-Specific Targeting of the T-Cell Receptor Variable Region as a Therapeutic Strategy in Clonal T-Cell Diseases.	Clin Cancer Res	2023
35868306	Integrative analysis of drug response and clinical outcome in acute myeloid leukemia.	Cancer Cell	2022
30333627	Functional genomic landscape of acute myeloid leukaemia.	Nature	2018
25895498	YM155 potently kills acute lymphoblastic leukemia cells through activation of the DNA damage pathway.	J Hematol Oncol	2015
26202934	Î²-Catenin is required for intrinsic but not extrinsic BCR-ABL1 kinase-independent resistance to tyrosine kinase inhibitors in chronic myeloid leukemia.	Leukemia	2015
23576564	Threshold levels of ABL tyrosine kinase inhibitors retained in chronic myeloid leukemia cells determine their commitment to apoptosis.	Cancer Res	2013
19823681	A BCR-ABL mutant lacking direct binding sites for the GRB2, CBL and CRKL adapter proteins fails to induce leukemia in mice.	PLoS One	2009
16880519	Kinase domain mutants of Bcr-Abl exhibit altered transformation potency, kinase activity, and substrate utilization, irrespective of sensitivity to imatinib.	Mol Cell Biol	2006
16772610	Comparison of imatinib mesylate, dasatinib (BMS-354825), and nilotinib (AMN107) in an N-ethyl-N-nitrosourea (ENU)-based mutagenesis screen: high efficacy of drug combinations.	Blood	2006
15665113	Synergistic interactions between imatinib mesylate and the novel phosphoinositide-dependent kinase-1 inhibitor OSU-03012 in overcoming imatinib mesylate resistance.	Blood	2005
12933582	In vitro efficacy of combined treatment depends on the underlying mechanism of resistance in imatinib-resistant Bcr-Abl-positive cell lines.	Blood	2004
14725908	Coexistence of phosphotyrosine-dependent and -independent interactions between Cbl and Bcr-Abl.	Exp Hematol	2004
12135670	In vitro studies of the combination of imatinib mesylate (Gleevec) and arsenic trioxide (Trisenox) in chronic myelogenous leukemia.	Exp Hematol	2002
11320143	Induction of mutant lymphocytes in cyclophosphamide- and chlorambucil-treated patients.	Mutagenesis	2001
9822717	Interactions of p62(dok) with p210(bcr-abl) and Bcr-Abl-associated proteins.	J Biol Chem	1998
8349586	Isolation and analysis of the gene and cDNA for a human Mu class glutathione S-transferase, GSTM4.	J Biol Chem	1993
2050131	Dose-dependent cytotoxic and mutagenic effects of antineoplastic alkylating agents on human lymphoblastoid cells.	Environ Mol Mutagen	1991

1 - 17 of 17

Amanda L Christie

Dana-Farber Cancer Institute

Career Start Year 2010

Number of shared co-authors 2

Vadym Zaberezhnyy

University of Colorado Anschutz Medical Campus

Career Start Year 2009

Number of shared co-authors 5

Anagha Deshpande

Sanford Burnham Prebys Medical Discovery Institute

Career Start Year 2009

Number of shared co-authors 0

Alexandre Puissant

Universite de Paris, INSERM, CNRS

Career Start Year 2007

Number of shared co-authors 1

Mateusz Koptyra

Children's Hospital of Philadelphia

Career Start Year 2004

Number of shared co-authors 0

Oliver Hantschel

Institute of Physiological Chemistry, University of Marburg 35032 Marburg Germany .

Career Start Year 2003

Number of shared co-authors 16

Christopher C Porter

Emory University School of Medicine

Career Start Year 2003

Number of shared co-authors 4

Thomas Ernst

Universitatsklinikum Jena

Career Start Year 2002

Number of shared co-authors 1

Mark A Gregory

University of Colorado Anschutz Medical Campus

Career Start Year 2000

Number of shared co-authors 5

Nikolas von Bubnoff

University Hospital of Schleswig-Holstein

Career Start Year 1997

Number of shared co-authors 3

Brian J P Huntly

University of Cambridge

Career Start Year 1996

Number of shared co-authors 8

Krister Wennerberg

University of Copenhagen

Career Start Year 1994

Number of shared co-authors 6

Ravi Bhatia

University of Alabama at Birmingham

Career Start Year 1992

Number of shared co-authors 5

Jerald P Radich

Fred Hutchinson Cancer Center

Career Start Year 1989

Number of shared co-authors 26

Aaron D Schimmer

Princess Margaret Cancer Centre

Career Start Year 1989

Number of shared co-authors 4

Lawrence H Boise

Winship Cancer Institute, Emory University

Career Start Year 1988

Number of shared co-authors 0

Suzanne Kamel-Reid

Toronto General Hospital, University Health Network, University of Toronto

Career Start Year 1988

Number of shared co-authors 3

Richard B Lock

Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine

Career Start Year 1987

Number of shared co-authors 2

Charles L Sawyers

Memorial Sloan Kettering Cancer Center

Career Start Year 1986

Number of shared co-authors 4

Marcela Gronda

Princess Margaret Cancer Centre

Career Start Year 1985

Number of shared co-authors 1

Jami McLaughlin

University of California los angeles

Career Start Year 1983

Number of shared co-authors 0

Hagop Kantarjian

The University of Texas MD Anderson Cancer Center

Career Start Year 1982

Number of shared co-authors 35

Bertram Opalka

University Hospital Essen.

Career Start Year 1982

Number of shared co-authors 2

Steven M Kornblau

The University of Texas MD Anderson Cancer Center

Career Start Year 1980

Number of shared co-authors 13

Douglas D Ross

Greenebaum Comprehensive Cancer Center, University of Maryland

Career Start Year 1979

Number of shared co-authors 0

Scott H Kaufmann

Mayo Clinic

Career Start Year 1977

Number of shared co-authors 7

Donald Small

Johns Hopkins University School of Medicine

Career Start Year 1977

Number of shared co-authors 0

Gordon B Mills

Knight Cancer Institute, Oregon Health and Sciences University

Career Start Year 1976

Number of shared co-authors 7

Alex Look

Dana-Farber Cancer Institute

Career Start Year 1975

Number of shared co-authors 13

Owen N Witte

University of California los angeles

Career Start Year 1972

Number of shared co-authors 1

row(s) 1 - 30 of 30

Brian J Druker

Oregon Health & Science University

Co-authored papers 13

Michael W Deininger

University of Utah Huntsman Cancer Institute

Co-authored papers 9

Thomas O'Hare

Huntsman Cancer Institute, University of Utah

Co-authored papers 5

Christopher A Eide

Knight Cancer Institute, Oregon Health & Science University

Co-authored papers 5

Marc M Loriaux

Knight Cancer Institute, Oregon Health & Science University

Co-authored papers 4

Jeffrey W Tyner

Oregon Health & Science University School of Medicine

Co-authored papers 4

Bill H Chang

Oregon Health and Science University

Co-authored papers 4

Russell T Burke

Knight Cancer Institute, Oregon Health & Science University

Co-authored papers 3

Jade Bryant

Knight Cancer Institute, Oregon Health & Science University

Co-authored papers 3

Anupriya Agarwal

Knight Cancer Institute, Oregon Health & Science University

Co-authored papers 3

Nicola Long

Oregon Health and Science University

Co-authored papers 2

Daniel A Pollyea

University of Colorado Division of Hematology

Co-authored papers 2

Dorian LaTocha

Knight Cancer Institute, Oregon Health & Science University

Co-authored papers 2

Kim-Hien T Dao

Astex Pharmaceuticals

Co-authored papers 2

Cristina E Tognon

Knight Cancer Institute, Oregon Health & Science University

Co-authored papers 2

Amanda d'Almeida

Knight Cancer Institute, Oregon Health & Science University

Co-authored papers 2

Haijiao Zhang

Oregon Health & Science University, Knight Cancer Institute

Co-authored papers 2

Elie Traer

Oregon Health & Science University

Co-authored papers 2

David Tyler Sweeney

Knight Cancer Institute, Oregon Health & Science University

Co-authored papers 2

Andy Kaempf

Knight Cancer Institute, Oregon Health & Science University

Co-authored papers 2

James Dibb

Knight Cancer Institute, Oregon Health & Science University

Co-authored papers 2

Aashis Thapa

Emory School of Medicine

Co-authored papers 2

Pierrette Lo

Knight Cancer Institute, Oregon Health & Science University

Co-authored papers 2

Jessica Leonard

Oregon Health & Science University

Co-authored papers 2

Aurora S Blucher

Knight Cancer Institute, Oregon Health Sciences University

Co-authored papers 2

Melissa L Abel

National Cancer Institute, National Institutes of Health

Co-authored papers 2

Justin M Watts

University of Miami, Sylvester Comprehensive Cancer Center

Co-authored papers 2

Joelle Wolf

Knight Cancer Institute, Oregon Health & Science University

Co-authored papers 2

Cody Coblentz

Knight Cancer Institute, Oregon Health & Science University

Co-authored papers 2

Stephanie G Willis

OHSU Cancer Institute

Co-authored papers 2

1 - 30

Author Details

Column Actions

Recommended Authors

Collaborators